Exploring new mechanisms in cancer molecular pathways and pathogenic cell transformation: PIP4K2A as a prognostic marker and therapeutic target in cutaneous malignant melanoma
Wen-fei Luo, Ding-ming Song, Tong Shen, Yi-bo He, Hong-yang Du, Ming-jue Si, Lu-Wei Fang · 2024
Read Exploring new mechanisms in cancer molecular pathways and pathogenic cell transformation: PIP4K2A as a prognostic marker and therapeutic target in cutaneous malignant melanoma by Wen-fei Luo, Ding-ming Song, Tong Shen, Yi-bo He, Hong-yang Du, Ming-jue Si, Lu-Wei Fang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11585527.txt.
Description
Melanoma of the skin is fierce and spreads early, and a gene called PIP4K2A may help drive it. Wen-fei Luo and co-authors investigated that gene in 2024, using single-cell sequencing of patient samples plus machine learning models. They focused on how the gene interacts with T cells, the immune cells that checkpoint drugs unleash against tumors.
The gene ran high in melanoma and tracked with worse stage and poorer outlook. Tumors with high levels answered immune therapy less well, and the gene counted as a risk factor for drug response. Lab staining of tissue confirmed the pattern. The authors present the gene as a marker for prognosis and a possible target, and as a clue to how T cells behave inside these tumors.
Catalog record
| CREATOR | Wen-fei Luo, Ding-ming Song, Tong Shen, Yi-bo He, Hong-yang Du, Ming-jue Si, Lu-Wei Fang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |